DEGs involved in the KEGG pathways or major PPI clusters were analyzed with Kaplan–Meier plotter to determine whether there were any associations between these genes and the RFS of patients with ER-positive/HER2-negative breast cancer who had undergone endocrine therapies only. The gene discussed is ERBB2; the disease is breast carcinoma.